NO972043L - Tienopyridin eller tienopyrimidinderivater og deres anvendelse - Google Patents

Tienopyridin eller tienopyrimidinderivater og deres anvendelse

Info

Publication number
NO972043L
NO972043L NO972043A NO972043A NO972043L NO 972043 L NO972043 L NO 972043L NO 972043 A NO972043 A NO 972043A NO 972043 A NO972043 A NO 972043A NO 972043 L NO972043 L NO 972043L
Authority
NO
Norway
Prior art keywords
tienopyridine
thienopyrimidine derivatives
thienopyridine
bone resorption
thienopyrimidine
Prior art date
Application number
NO972043A
Other languages
English (en)
Norwegian (no)
Other versions
NO972043D0 (no
Inventor
Takashi Sohda
Haruhiko Makino
Atsuo Baba
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO972043D0 publication Critical patent/NO972043D0/no
Publication of NO972043L publication Critical patent/NO972043L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO972043A 1994-11-08 1997-05-02 Tienopyridin eller tienopyrimidinderivater og deres anvendelse NO972043L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP27380194 1994-11-08
JP32005594 1994-12-22
PCT/JP1995/002271 WO1996014319A1 (en) 1994-11-08 1995-11-07 Thienopyridine or thienopyrimidine derivatives and their use

Publications (2)

Publication Number Publication Date
NO972043D0 NO972043D0 (no) 1997-05-02
NO972043L true NO972043L (no) 1997-06-25

Family

ID=26550777

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972043A NO972043L (no) 1994-11-08 1997-05-02 Tienopyridin eller tienopyrimidinderivater og deres anvendelse

Country Status (12)

Country Link
US (1) US5747486A (de)
EP (1) EP0791000B1 (de)
KR (1) KR970707131A (de)
AT (1) ATE225351T1 (de)
AU (1) AU699354B2 (de)
CA (1) CA2202985A1 (de)
DE (1) DE69528470T2 (de)
FI (1) FI971974A7 (de)
HU (1) HUT77348A (de)
NO (1) NO972043L (de)
NZ (1) NZ294933A (de)
WO (1) WO1996014319A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ331802A (en) * 1996-04-25 1999-06-29 Takeda Chemical Industries Ltd Thienopyridine derivatives and their use as an anti-inflammatory drug for preventing or treating arthritis and inhibiting bone resorption
US5939432A (en) * 1997-10-29 1999-08-17 Medco Research, Inc. Thiophenes useful for modulating the adenosine receptor
US6323214B1 (en) 1997-10-29 2001-11-27 Medco Research, Inc Allosteric adenosine receptor modulators
US6727258B2 (en) * 1997-10-29 2004-04-27 King Pharmaceutical Research & Development, Inc. Allosteric adenosine receptor modulators
US6232320B1 (en) 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
TW564247B (en) * 1999-04-08 2003-12-01 Akzo Nobel Nv Bicyclic heteraromatic compound
TW591031B (en) * 2000-02-29 2004-06-11 Takeda Chemical Industries Ltd Thienopyridine derivatives, their production and use
US6503914B1 (en) 2000-10-23 2003-01-07 Board Of Regents, The University Of Texas System Thienopyrimidine-based inhibitors of the Src family
BR0207216A (pt) * 2001-02-14 2004-03-09 Warner Lambert Co Derivados de tieno 2,3-d-pirimidindiona como inibidores de metaloproteinase matriz
WO2003018590A1 (fr) * 2001-08-24 2003-03-06 Takeda Chemical Industries, Ltd. Procede de production d'un derive de la thienopyridine
US7049333B2 (en) 2002-06-04 2006-05-23 Sanofi-Aventis Deutschland Gmbh Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
BR0312744A (pt) * 2002-07-17 2005-04-26 Warner Lambert Co Associação de um inibidor carboxìlico alostérico da metaloproteinase-13 de matriz com um inibidor selectivo da ciclooxigenase-2, à excepção do celecoxib ou valdecoxib
TW200410975A (en) * 2002-09-26 2004-07-01 Nihon Nohyaku Co Ltd New pesticide and method for using it, new substituted thienopyrimidine derivative, its intermediate, and method for producing it
CN1984660B (zh) 2003-07-03 2010-12-15 美瑞德生物工程公司 作为天冬氨酸特异性半胱氨酸蛋白酶活化剂和细胞程序死亡诱导剂的4-芳基氨基-喹唑啉
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
DE602005014383D1 (en) * 2004-12-17 2009-06-18 Hoffmann La Roche Thienopyridinderivate als allostere gaba-b-enhancer
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
EP1833482A4 (de) 2005-01-03 2011-02-16 Myriad Genetics Inc Verbindungen und ihre therapeutische verwendung
MX2007014929A (es) 2005-06-02 2008-02-15 Hoffmann La Roche 3-metansulfonilquinolinas como mejoradores de gaba-b.
WO2007056214A2 (en) * 2005-11-02 2007-05-18 Cytovia, Inc N-alkyl-n-aryl-thienopyrimidin-r-amines and uses thereof
US20070099941A1 (en) * 2005-11-02 2007-05-03 Cytovia, Inc. N-arylalkyl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
US20070099877A1 (en) * 2005-11-02 2007-05-03 Cytovia, Inc. N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
US7956068B2 (en) * 2007-11-15 2011-06-07 Boehringer Ingelheim International Gmbh Inhibitors of human immunodeficiency virus replication
US8575403B2 (en) 2010-05-07 2013-11-05 Celanese International Corporation Hydrolysis of ethyl acetate in ethanol separation process
US8859827B2 (en) 2011-11-18 2014-10-14 Celanese International Corporation Esterifying acetic acid to produce ester feed for hydrogenolysis
US8664454B2 (en) 2010-07-09 2014-03-04 Celanese International Corporation Process for production of ethanol using a mixed feed using copper containing catalyst
US8846988B2 (en) 2010-07-09 2014-09-30 Celanese International Corporation Liquid esterification for the production of alcohols
US8710279B2 (en) 2010-07-09 2014-04-29 Celanese International Corporation Hydrogenolysis of ethyl acetate in alcohol separation processes
US8704008B2 (en) 2010-07-09 2014-04-22 Celanese International Corporation Process for producing ethanol using a stacked bed reactor
US9272970B2 (en) 2010-07-09 2016-03-01 Celanese International Corporation Hydrogenolysis of ethyl acetate in alcohol separation processes
US8907141B2 (en) 2011-04-26 2014-12-09 Celanese International Corporation Process to recover alcohol with secondary reactors for esterification of acid
US8592635B2 (en) 2011-04-26 2013-11-26 Celanese International Corporation Integrated ethanol production by extracting halides from acetic acid
US9073816B2 (en) 2011-04-26 2015-07-07 Celanese International Corporation Reducing ethyl acetate concentration in recycle streams for ethanol production processes
US9000233B2 (en) 2011-04-26 2015-04-07 Celanese International Corporation Process to recover alcohol with secondary reactors for hydrolysis of acetal
US8754268B2 (en) 2011-04-26 2014-06-17 Celanese International Corporation Process for removing water from alcohol mixtures
US8895786B2 (en) 2011-08-03 2014-11-25 Celanese International Corporation Processes for increasing alcohol production
US8829251B2 (en) 2011-11-18 2014-09-09 Celanese International Corporation Liquid esterification method to produce ester feed for hydrogenolysis
US8802901B2 (en) 2011-11-18 2014-08-12 Celanese International Corporation Continuous ethyl acetate production and hydrogenolysis thereof
US8748673B2 (en) 2011-11-18 2014-06-10 Celanese International Corporation Process of recovery of ethanol from hydrogenolysis process
US8853468B2 (en) 2011-11-18 2014-10-07 Celanese International Corporation Vapor esterification method to produce ester feed for hydrogenolysis
US8829249B2 (en) 2011-11-18 2014-09-09 Celanese International Corporation Integrated esterification and hydrogenolysis process for producing ethanol
US9024089B2 (en) 2011-11-18 2015-05-05 Celanese International Corporation Esterification process using extractive separation to produce feed for hydrogenolysis
US8927790B2 (en) 2011-12-15 2015-01-06 Celanese International Corporation Multiple vapor feeds for hydrogenation process to produce alcohol
US8975451B2 (en) 2013-03-15 2015-03-10 Celanese International Corporation Single phase ester feed for hydrogenolysis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5143796A (ja) * 1974-10-09 1976-04-14 Yoshitomi Pharmaceutical Shinkinachenopirimijinruino seizoho
JPS5246095A (en) * 1975-10-07 1977-04-12 Yoshitomi Pharmaceut Ind Ltd Preparation of novel thienopyrimidine derivatives
DE3502392A1 (de) * 1985-01-25 1986-07-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen

Also Published As

Publication number Publication date
NZ294933A (en) 1999-05-28
FI971974A0 (fi) 1997-05-07
EP0791000A1 (de) 1997-08-27
AU699354B2 (en) 1998-12-03
NO972043D0 (no) 1997-05-02
FI971974L (fi) 1997-06-18
WO1996014319A1 (en) 1996-05-17
ATE225351T1 (de) 2002-10-15
DE69528470D1 (de) 2002-11-07
CA2202985A1 (en) 1996-05-17
FI971974A7 (fi) 1997-06-18
HUT77348A (hu) 1998-03-30
EP0791000B1 (de) 2002-10-02
US5747486A (en) 1998-05-05
DE69528470T2 (de) 2003-08-21
AU3815895A (en) 1996-05-31
KR970707131A (ko) 1997-12-01

Similar Documents

Publication Publication Date Title
NO972043L (no) Tienopyridin eller tienopyrimidinderivater og deres anvendelse
NO991951L (no) Tienopyrimidiner med fosfodiesterase V-inhiberende virkning
NO941679D0 (no) Gallesyrederivater, fremgangsmåte for fremstilling og deres anvendelse
NO992821L (no) Ketobenzamider som calpain-inhibitorer
NO972972D0 (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
NO963860L (no) Isoprenyl-transferase-inhibitorer
NO992492L (no) Benzamidoaldehyder og deres anvendelse som cystein-protease-inhibitorer
FI954718L (fi) Heterosykliset johdannaiset iskeemian ja vastaavien sairauksien hoitamiseksi
DK620489A (da) Enzymhaemmende urinstofderivater af dipeptider, deres fremstilling og anvendelse som laegemidler
NO924433D0 (no) Isoksazol-4-karboksylsyreamider og hydroksyalkyliden-cyaneddiksyreamider, legemidler inneholdende disse forbindelsene og deres anvendelse
NO951900L (no) Stilkskrue og bakenforliggende spinalinstrumentering
AR008853A1 (es) Nuevos compuestos farmaceuticamente activos, su uso en la fabricacion de medicamentos, metodo de tratamiento, composicion farmaceutica, compuestosintermediarios y proceso para la fabricacion de dichos compuestos
ATE231837T1 (de) Hydroxamsäure- und carbonsäurederivate mit mmp und tnf hemmender wirkung
NO975710L (no) Nye Dolastatinderivater, deres fremstilling og anvendelse
AP9100310A0 (en) Tnf inhibitors
FI962022L (fi) 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina
NO943682D0 (no) Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
AU6484994A (en) Seed treatment using phosphorous acid or one of its salts, and seeds thus treated
EP0678031A4 (de) Aus gewebe stammende tumorwachstumsinhibitoren, methoden zu deren herstellung und verwendungen davon.
PL310348A1 (en) Substituted derivatives of azolone for use in treating diseases caused by heliobacter
NO20016201L (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
ES2060918T3 (es) Derivados de ciclopropilo que poseen actividad inhibidora lipoxigenasa.
ATE303154T1 (de) Verwendung von einem trifluridin derivat allein oder in kombination mit einem thymidin- phosphorylase-hemmer zur behandlung von hiv
IS3951A (is) Cephalosporinafleiður, aðferð til framleiðslu þeirra og notkunar sem lyfja
FI891813L (fi) Mikro-organismeja tappava/mikro-organismien kasvua estävä koostumus teollista käyttöä varten sekä menetelmä mikro-organismien tappamiseksi tai niiden kasvun estämiseksi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application